Maxlive Pharmaceuticals Profile
Key Indicators
- Authorised Capital ₹ 3.00 M
- Paid Up Capital ₹ 3.00 M
- Company Age 13 Year, 1 Month
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 6.59 Cr
- Satisfied Charges ₹ 8.00 M
- Revenue Growth -31.26%
- Profit Growth -23.75%
- Ebitda -29.58%
- Net Worth 16.95%
- Total Assets 26.14%
About Maxlive Pharmaceuticals
Maxlive Pharmaceuticals Private Limited (MPPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 December 2011 and has a history of 13 years and one month. Its registered office is in Sahibabad, Uttar Pradesh, India.
The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 3.00 M and a paid-up capital of Rs 3.00 M.
The company currently has active open charges totaling ₹6.59 Cr. The company has closed loans amounting to ₹8.00 M, as per Ministry of Corporate Affairs (MCA) records.
Manoj Kumar and Ankur Vashishtha serve as directors at the Company.
Company Details
-
Location
Sahibabad, Uttar Pradesh, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U24233UP2011PTC048133
-
Company No.
048133
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Dec 2011
-
Date of AGM
30 Sep 2023
-
Date of Balance Sheet
31 Mar 2023
-
Listing Status
Unlisted
-
ROC Code
Roc Kanpur
Industry
Who are the key members and board of directors at Maxlive Pharmaceuticals?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Manoj Kumar
|
Director | 29-Dec-2011 | Current |
|
Ankur Vashishtha
|
Director | 03-Nov-2018 | Current |
Financial Performance of Maxlive Pharmaceuticals.
Maxlive Pharmaceuticals Private Limited, for the financial year ended 2023, experienced significant reduction in revenue, with a 31.26% decrease. The company also saw a substantial fall in profitability, with a 23.75% decrease in profit. The company's net worth Soared by an impressive increase of 16.95%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Maxlive Pharmaceuticals?
In 2023, Maxlive Pharmaceuticals had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
-
Mvp Prospera LlpManoj Kumar is a mutual person
Charges (Loans)
₹65.91 M
₹8.00 M
Charges Breakdown by Lending Institutions
- Others : 3.10 Cr
- Hdfc Bank Limited : 3.00 Cr
- Indian Bank : 0.49 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 15 Mar 2024 | Others | ₹1.01 M | Open |
| 14 Jun 2023 | Others | ₹3.00 Cr | Open |
| 06 Oct 2020 | Hdfc Bank Limited | ₹3.00 Cr | Open |
| 20 Jan 2020 | Indian Bank | ₹4.90 M | Open |
| 03 Feb 2020 | Others | ₹8.00 M | Satisfied |
How Many Employees Work at Maxlive Pharmaceuticals?
Unlock and access historical data on people associated with Maxlive Pharmaceuticals, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Maxlive Pharmaceuticals, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Maxlive Pharmaceuticals's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
